Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labcorp HoldingsLTS:0JSY 77 3-Year Dividend Growth Rate is 10.10% as of Jun. 2026, which is at its 10-year median of 10.10. GuruFocus rates LTS:0JSY with a GF Score™ of 77/100 and a GF Value™ of $277.58 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 49 Medical Diagnostics & Research companies, Labcorp Holdings ranks better than 51.02% on this metric.
The historical rank and industry rank for Labcorp Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:
LTS:0JSY'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -33.3 Med: 10.1 Max: 74.7
Current: 10.1
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Labcorp Holdings was 74.70% per year. The lowest was -33.30% per year. And the median was 10.10% per year.
LTS:0JSY's 3-Year Dividend Growth Rate is ranked better than 51.02% of 49
companies
in the Medical Diagnostics & Research industry
Industry Median: 10.1
vs LTS:0JSY: 10.10
During the past 3 years, the average Dividends Per Share Growth Rate was 10.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Labcorp Holdings was 0.25. The lowest was 0.11. And the median was 0.21.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Labcorp Holdings Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.720000
2026-08-28
2026-08-28
2026-09-11
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.720000
2026-05-29
2026-05-29
2026-06-11
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.720000
2026-02-27
2026-02-27
2026-03-12
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.720000
2025-11-26
2025-11-26
2025-12-11
Cash Dividend
quarterly
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Labcorp Holdings's Dividend Yield (%) for Today is calculated as
Current Share Price is $335.21.
Labcorp Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.88.
During the past 13 years, the highest Dividend Yield of Labcorp Holdings was 1.56%. The lowest was 0.32%. And the median was 1.16%.
Warning Sign:
Labcorp Holdings Inc stock Dividend Yield % is close to 3-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings 3-Year Dividend Growth Rate Related Terms>
LTS:0JSY vs DGX, MTD, ILMN: 3-Year Dividend Growth Rate Comparison
For the Diagnostics & Research subindustry, Labcorp Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings 3-Year Dividend Growth Rate vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 10.10% mean?
Labcorp Holdings (LTS:0JSY) has a 3-Year Dividend Growth Rate of 10.10% as of Jun. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Labcorp Holdings and its competitors. This is near median its historical median of 10.10. According to the industry distribution chart, Labcorp Holdings ranks #24 out of 49 companies in the Medical Diagnostics & Research industry, placing it in the top 49%.
Is Labcorp Holdings' 3-Year Dividend Growth Rate too high?
Labcorp Holdings' current 3-Year Dividend Growth Rate of 10.10% is near median its 10-year median of 10.10. The Medical Diagnostics & Research industry median 3-Year Dividend Growth Rate is 10.10. Labcorp Holdings' value of 10.10% is 0% at this industry median. Based on the distribution chart, Labcorp Holdings ranks #24 out of 49 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' 3-Year Dividend Growth Rate compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #24 out of 49 companies for 3-Year Dividend Growth Rate. This puts Labcorp Holdings in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 10.10. Labcorp Holdings' value of 10.10% is 0% at this benchmark. While the company's 10-year median is 10.10 vs. the industry median of 10.10, Labcorp Holdings has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Diagnostics & Research company?
The median 3-Year Dividend Growth Rate among Medical Diagnostics & Research companies is 10.10, based on 49 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labcorp Holdings's current 3-Year Dividend Growth Rate of 10.10% is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Labcorp Holdings and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year Dividend Growth Rate is 10.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labcorp Holdings's current 3-Year Dividend Growth Rate is 10.10%, which is near median its own 10-year median of 10.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Modestly Overvalued. The stock's GF Value™ is $277.58, compared to a current price of $335.21 — trading 20.8% above its estimated fair value. The current 3-Year Dividend Growth Rate is 10.10%, which is near median its 10-year median of 10.10 and 0% at the Medical Diagnostics & Research industry median of 10.10. Labcorp Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current 3-Year Dividend Growth Rate is 10.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $335.21 is trading 20.8% above its estimated GF Value™ of $277.58.
GuruFocus considers Labcorp Holdings to be Modestly Overvalued.
Key valuation signals for LTS:0JSY:
3-Year Dividend Growth Rate: 10.10% (near median its 10-year median of 10.10)
GF Value™: $277.58 vs. price of $335.21 (20.8% above fair value)
Industry Position: 0% at the Medical Diagnostics & Research median (#24 of 49)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
77GF Score
Get the complete analysis for LTS:0JSY
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
